EpiPen maker settles $465 million lawsuit

Sept. 21, 2016: Mylan CEO Heather Bresch holds up EpiPens while testifying on Capitol Hill in Washington, before the House Oversight Committee hearing on EpiPen price increases.  (AP Photo/Pablo Martinez Monsivais, File) Drugmaker Mylan will pay $465 million to settle allegations that it overbilled Medicaid for its life-saving EpiPen, ending one of the controversies over […]